LATAM Director , Market Access Pipeline; Specialty Pharma Infectious Disease

LATAM New Products SPID Access Director

The LATAM NP SPID Access Director is responsible for leading access and pricing strategy for new products launch acceleration and supporting new product planning and acceleration management across SPID launches. This role is designed to create and sustain a dedicated LATAM launch engine that enables successful access, reimbursement, and patient adoption across multiple assets and markets in a compressed launch window.

The ideal candidate will be a strategic and hands-on access leader with deep expertise in market access, pricing, reimbursement, HTA, and launch excellence across Latin America. This role requires someone who can build repeatable accelerated launch processes, coordinate across assets, and adapt strategies to very different payer, reimbursement, and healthcare environments across LATAM. The leader will partner closely with local country teams, regional functions, and global stakeholders to accelerate access readiness, protect value, and ensure disciplined execution across the SPID portfolio.

This role is critical to enabling launch excellence across LATAM by establishing scalable access capabilities, harmonizing ways of working across countries, and ensuring that each asset benefits from an efficient, repeatable, and high-quality regional launch framework.

• Lead the development and execution of market access and pricing strategies for and other priority pharma assets across LATAM.
• Build and lead a dedicated LATAM launch engine to support launch acceleration, ensuring repeatable, scalable, and high-quality access processes across multiple assets and countries.
• Serve as the LATAM access lead SPID product launch acceleration priorities.
• Develop LATAM specific access acceleration strategies that address differing payer environments, reimbursement pathways, and market access requirements across assets and countries.
• Prioritize resources and leadership attention toward the highest-value and highest-feasibility launches, ensuring appropriate focus across the portfolio and region.
• Partner with country market access teams to align global & regional strategy with local access needs, launch timelines, and business priorities.
• Establish and implement standardized launch readiness tools, templates, governance, and decision-making processes to improve speed and consistency.
• Guide pricing strategy and governance to support value protection, prevent regional price erosion, and manage private and public procurement complexity.
• Support access evidence generation, payer value communication, and stakeholder engagement strategies that strengthen launch acceleration and success.
• Monitor policy, payer, and competitor dynamics to anticipate risks and opportunities during launch planning and lifecycle management.
• Collaborate closely with Medical, Commercial, Regulatory, Policy, Legal, and Global teams to deliver integrated launch acceleration plans.
• Share best practices across markets and assets to continuously improve the launch engine and support future accelerated launches.
• Ensure compliance with all applicable legal, regulatory, and ethical standards.

• Bachelors or Advanced degree in life sciences, pharmacy, public health, business, economics, or related field.
• Minimum of 8 years of experience in market access, pricing, reimbursement, new product planning, or related launch functions in the pharmaceutical industry.
• Demonstrated experience supporting launch strategy or access readiness for innovative pharmaceutical products.
• Strong understanding of HTA, reimbursement, payer systems, and pricing dynamics across multiple markets.

• Launch excellence experience and acceleration leadership
• Market access and pricing expertise
• New product planning
• Repeatable process and operating model design
• Pricing governance and value protection
• HTA and reimbursement strategy
• Stakeholder management and cross-functional collaboration
• Influence and negotiation
• Analytical and strategic problem solving
• Communication and presentation skills
• Ability to manage multiple priorities in a fast-paced matrix environment
• Adaptability across multiple payer and healthcare systems

• Pharma priority assets have strong LATAM access readiness and launch plans well ahead of launch.
• A dedicated LATAM launch acceleration engine is established with repeatable processes that can be applied across multiple assets and countries.
• Pricing decisions to protect value across LATAM markets.
• LATAM teams aligned and equipped to execute launches across very different payer environments.
• Launch acceleration improves speed to access, consistency, and overall launch quality across the SPID portfolio.

Cross-Cultural Awareness, Go-to-Market Strategies, Healthcare Reimbursement, Market Access, Market Access Strategies, Pharmaceutical Industry, Pharmaceutics, Pricing Processes, Pricing Strategies, Project Planning, Results-Oriented, Strategic Planning, Strategic Thinking, Value Propositions